# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week...
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
A Contract Research Organization (CRO) and a wholly-owned subsidiary of Wellbeing Digital Sciences Inc.
This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved i...
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, N...
Wellbeing Digital (OTC: KONEF) subsidiary KGK Sciences will advance with the first-ever Phase 2a clinical trial assessing repet...
In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council.
The partnership leading the way on psilocybin therapy for Fragile X Syndrome (FXS), the major genetic cause of Autism Spectrum ...
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIM...